Chimeric viral vectors - The best of both worlds?

Molecular Medicine Today

Volumn 5, Issue 1, 1999, Pages 25-31

  Reynolds, Paul N ^a   Feng, Meizhen ^a   Curiel, David T ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ANIMAL; CELL CULTURE; CHIMERA; GENE TARGETING; GENE THERAPY; GENE VECTOR; GENETICS; HUMAN; METHODOLOGY; REVIEW;

ANIMALS; CELLS, CULTURED; CHIMERA; DNA, VIRAL; GENE TARGETING; GENE THERAPY; GENETIC VECTORS; HUMANS;

EID: 0032618661     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(98)01378-1     Document Type: Review

References (49)

1. Anderson, W.F. and Fletcher, J.C. (1980) Sounding boards. Gene therapy in human beings: when is it ethical to begin? New Engl. J. Med. 303, 1293-1297
2. Kerr, W.G. (1998) Genetic modification of the hematolymphoid compartment for therapeutic purposes, Hematol. Oncol. Clin. North. Am. 12, 503-518
3. Aoki, M. et al. (1997) Survival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and the b-galactosidase gene in the noninfarcted area, but not the myocardial infarcted area, Gene Ther. 4, 120-127
4. Overturf, K. et al. (1998) Ex vivo hepatic gene therapy of a mouse model of hereditary tyrosinemia type I, Hum. Gene Ther. 9, 295-304
5. Brody, S.L. and Crystal, R.G. (1994) Adenovirus-mediated in vivo gene transfer, Ann. New York Acad. Sci. 716, 90-101
6. Smith, T.A. et al. (1993) Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice, Nat. Genet. 5, 397-402
7. Jaffe, H.A. et al. (1992) Adenovirus-mediated in vivo gene transfer and expression in normal rat liver, Nat. Genet. 1, 372-378
8. Tomko, R.P., Xu, R. and Philipson, L. (1997) HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses, Proc. Natl Acad. Sci. U. S. A. 94, 3352-3356
9. Bergelson, J.M. et al. (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5, Science 275, 1320-1323
10. Hong, S.S. et al. (1997) Adenovirus type 5 fiber knob binds to MHC class I α-2 domain at the surface of human epithelial and B lymphoblastoid cells, EMBO J. 16, 2294-2306
11. Wickham, T.J., Mathias, P., Cheresh, D.A. and Nemerow, G.R. (1993) Integrins αv β3 and αv β5 promote adenovirus internalization but not virus attachment, Cell 73, 309-319
12. Schulick, A.H. et al. (1995) Endothelium-specific in vivo gene transfer, Circ. Res. 77, 475-485
13. Schulick, A.H., Newman, K.D., Virmani, R. and Dichek, D.A. (1995) In vivo gene transfer into injured carotid arteries. Optimization and evaluation of acute toxicity, Circulation 91, 2407-2414
14. Douglas, J.T. et al. (1996) Targeted gene delivery by tropism-modified adenoviral vectors, Nat. Biotechnol. 14, 1574-1578
15. Rancourt, C. et al. (1998) FGF2-enhancement of adenovirus-mediated delivery of the herpes simplex virus thymidine kinase gene results in augmented therapeutic benefit in a murine model of ovarian cancer, Clin. Cancer Res. 4, 2455-2461
16. Krasnykh, V. et al. (1998) Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob, J. Virol. 72, 1844-1852
17. Wickham, T.J. et al. (1997) Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins, J. Virol. 71, 8221-8229
18. Crystal, R.G. et al. (1994) Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis, Nat. Genet. 8, 42-51
19. Brody, S.L. et al. (1994) Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA, Hum. Gene Ther. 5, 821-836
20. Worgall, S., Wolff, G., Falck-Pedersen, E. and Crystal, R.G. (1997) Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration, Hum. Gene Ther. 8, 37-44
21. Yang, Y., Li, Q., Ertl, H.C. and Wilson, J.M. (1995) Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses, J. Virol. 69, 2004-2015
22. Schiedner, G. et al. (1998) Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity, Nat. Genet. 18, 180-183
23. Shenk, T. (1996) Adenoviridae: the viruses and their replication, in Fields Virology (Fields, B.N., Knipe, D.M. and Howley, P.M., eds), pp. 2111-2148, Lippincott-Raven
24. Samulski, R.J. et al. (1991) Targeted integration of adeno-associated virus (AAV) into human chromosome 19, EMBO J. 10, 3941-3950
25. Vile, R.G. and Russell, S.J. (1995) Retroviruses as vectors, Br. Med. Bull. 51, 12-30
26. Wohlgemuth, J.G. et al. (1996) Long-term gene expression from autonomously replicating vectors in mammalian cells, Gene Ther. 3, 503-512
27. Snyder, R.O. et al. (1997) Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors, Nat. Genet. 16, 270-276
28. Monahan, P.E. et al. (1998) Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia, Gene Ther. 5, 40-49
29. Xiao, X., Li, J. and Samulski, R.J. (1998) Production of high-liter recombinant adeno-associated virus vectors in the absence of helper adenovirus, J. Virol. 72, 2224-2232
30. Zufferey, R. et al. (1997) Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo, Nat. Biotechnol. 15, 871-875
31. Zavada, J. (1982) The pseudotypic paradox, J. Gen. Virol. 63, 15-24
32. Yee, J.K., Friedmann, T. and Burns, J.C. (1994) Generation of high-liter pseudolyped retroviral vectors with very broad host range, Methods Cell Biol. 43, 99-112
33. Schnierle, B.S. et al. (1997) Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells, Proc. Natl. Acad. Sci. U. S. A. 94, 8640-8645
34. Pensiero, M.N., Wysocki, C.A., Nader, K. and Kikuchi, G.E. (1996) Development of amphotropic murine retrovirus vectors resistant to inactivation by human serum, Hum. Gene Ther. 7, 1095-1101
35. Yoshida, Y, Emi, N. and Hamada, H. (1997) VSV-G-pseudolyped retroviral packaging through adenovirus-medialed inducible gene expression, Biochem. Biophys. Res. Commun. 232, 379-382
36. Li, K.J. and Garoff, H. (1996) Production of infectious recombinant Moloney murine leukemia virus particles in BHK cells using Semliki Forest virus-derived RNAexpression vectors, Proc. Natl. Acad. Sci. U. S. A. 93, 11658-11663
37. Fisher, K.J., Kelley, W.M., Burda, J.F. and Wilson, J.M. (1996) A novel adenovirus-adeno-associated virus hybrid vector that displays efficient rescue and delivery of the AAV genome, Hum. Gene Ther. 7, 2079-2087
38. Palombo, F. et al. (1998) Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector, J. Virol. 72, 5025-5034
39. Fraefel, C. et al. (1997) Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors, Mol. Med. 3, 813-825
40. Johnston, KM. et al. (1997) HSV/AAV hybrid amplicon vectors extend trans-gene expression in human glioma cells, Hum. Gene Ther. 8, 359-370
41. Wang, S. and Vos, J.M. (1996) A hybrid herpesvirus infectious vector based on Epstein-Barr virus and herpes simplex virus type 1 for gene transfer into human cells in vitro and in vivo, J. Virol. 70, 8422-8430
42. Bilbao, G. et al. (1997) Adenoviral/retroviral vector chimeras: a novel strategy to achieve high-efficiency stable transduction in vivo, FASEB J. 11, 624-634
43. Feng, M.Z. et al. (1997) Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector, Nat. Biotechnol 15, 866-870
44. Welsh, R.M., Jr, Cooper, N.R., Jensen, F.C. and Oldstone, M.B. (1975) Human serum lyses RNA tumour viruses, Nature 257, 612-614
45. Oldfield, E.H. et al. (1993) Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir, Hum. Gene Ther. 4, 39-69
46. Noguiez-Hellin, P., Meur, M.R., Salzmann, J.L. and Klatzmann, D. (1996) Plasmoviruses: nonviral/viral vectors for gene therapy, Proc. Natl Acad. Sci. U. S. A. 93, 4175-4180
47. Ramsey, W.J. et al. (1998) Adenovirus vectors as transcomplementing templates for the production of replication defective retroviral vectors, Biochem. Biophys. Res. Commun. 246, 912-919
48. Morsy, M.A. and Caskey, C.T. (1998) Expanded-capacity adenoviral vectors - the helper-dependent vectors, Mol. Med. Today 5, 18-24
49. Patijn, G.A. et al. (1998) High-efficiency retrovirus-mediated gene transfer into the livers of mice, Hum. Gene Ther. 9, 1449-1456